New Drug Scores Against Crohn's - 06/20/16 09:38 PM
Big Pharma AbbVie (ABBV) said Tuesday that a recently licensed drug candidate succeeded in a phase-two trial of Crohn’s disease, as the company seeks to refresh its blockbuster immunology franchise." (more...)
http://neverignore.pw/abbvies-newly-licensed-drug-scores-against-crohns-disease/#comments
Good, good - crossed fingers - hope no horrid side effects...
http://neverignore.pw/abbvies-newly-licensed-drug-scores-against-crohns-disease/#comments
Good, good - crossed fingers - hope no horrid side effects...